Results came from a phase 1 trial of RP-A501 for treatment of Danon Disease and sent shares up 75% on the Nasdaq to more than $56, a five-year high. The surging stock price indicates the market's ...
After being blindsided by the upstart -- Chobani became the biggest U.S. seller of Greek yogurt two years after releasing its first product -- the world’s largest yogurt maker aims to take back the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback